ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673095; 2) Community: the network communities that were significantly associated with the response to NSC 673095; 3) Molecule: the relationships between components within communities and NSC 673095; 4) MDR: the compounds that were significantly associated with the NSC 673095.

NSC Compound Enrichment Correlation
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.0284045326811616 -0.050536022
NSC 646847 Bengamide G 0.0284045326811616 0.30289186
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0284045326811616 0.31833872
NSC 665759 Null 0.0284045326811616 0.044289442
NSC 668476 Null 0.0284045326811616 0.18340225
NSC 676372 Null 0.0284045326811618 0.1240176
NSC 681636 Camptothecin Derivative 0.0284045326811618 0.37907287
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0284045326811618 0.18807295
NSC 683558 Camptothecin Derivative 0.0284045326811618 0.37530357
NSC 691243 Null 0.0284045326811618 0.33775378
Total:80  Current:46    [First] [Prev] [Next] [Last]